ArticlePloS one2018
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.
Celine Saint-Laurent et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it